[Bone metastases of prostatic cancer in relation to tumor size and grade of malignancy (author's transl)]
- PMID: 7402942
[Bone metastases of prostatic cancer in relation to tumor size and grade of malignancy (author's transl)]
Abstract
In 153 patients with prostatic cancer total body bone scintigraphy was performed. Forty six patients showed bone metastases while there was no evidence of skeletal involvement in 101 cases. Our results show that the tendency of bone metastases increases when low differentiated type of malignancy is present: Patients with low grade malignancy (G1) showed bone metastases in 7.3%, with middle grade malignancy (G2) in 40%, and with high grade malignancy (G3) in 38.5%. We were also able to establish a correlation between tumor size and frequency of bone metastases: Patients with tumor size T1 showed bone metastase in 7.1%, with tumor size T2 in 19.3%, with tumor size T3 in 39.2%, and with tumor size T4 in 65%. Furthermore, we found that the incidence of low differentiated tumors appeared to be more common in increased tumor size. These results show the value of early detection of prostatic cancer.
Similar articles
-
[Radionuclide diagnosis and therapy of skeletal metastases of prostatic cancer].Radiologe. 1984 Jan;24(1):13-8. Radiologe. 1984. PMID: 6200897 German.
-
[The usefulness of early whole body bone scintigraphy in the detection of bone metastasis from prostatic cancer].Kaku Igaku. 1994 Jun;31(6):541-50. Kaku Igaku. 1994. PMID: 7520953 Japanese.
-
[Bone metastases of prostatic neoplasms with reference to the histological type and local tumor stage].Schweiz Med Wochenschr. 1980 Jan;110(1):11-5. Schweiz Med Wochenschr. 1980. PMID: 6244617 German.
-
[The importance of bone scintigraphy in the aftercare of patients with malignancies].Radiologe. 1990 Oct;30(10):465-71. Radiologe. 1990. PMID: 2255752 Review. German.
-
Skeletal scintigraphy.West J Med. 1979 Jun;130(6):503-14. West J Med. 1979. PMID: 390886 Free PMC article. Review.
Cited by
-
Bone scintigraphy predicts the risk of spinal cord compression in hormone-refractory prostate cancer.Eur J Nucl Med Mol Imaging. 2004 Jul;31(7):958-63. doi: 10.1007/s00259-004-1479-z. Epub 2004 Feb 19. Eur J Nucl Med Mol Imaging. 2004. PMID: 14985870 Clinical Trial.
MeSH terms
LinkOut - more resources
Medical